Clover Health Investments (CLOV) Depreciation & Amortization (CF) (2020 - 2025)
Clover Health Investments' Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $420000.0 for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) rose 209.38% year-over-year to $420000.0; the TTM value through Dec 2025 reached $783000.0, up 29.85%, while the annual FY2025 figure was $1.7 million, 166.8% up from the prior year.
- Depreciation & Amortization (CF) reached $420000.0 in Q4 2025 per CLOV's latest filing, up from $406000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.6 million in Q4 2023 to a low of -$3.3 million in Q1 2023.
- Average Depreciation & Amortization (CF) over 5 years is $308050.0, with a median of $324000.0 recorded in 2024.
- The largest YoY upside for Depreciation & Amortization (CF) was 825.1% in 2023 against a maximum downside of 19041.18% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $58000.0 in 2021, then tumbled by 1432.76% to -$773000.0 in 2022, then skyrocketed by 825.1% to $5.6 million in 2023, then crashed by 106.85% to -$384000.0 in 2024, then surged by 209.38% to $420000.0 in 2025.
- Per Business Quant, the three most recent readings for CLOV's Depreciation & Amortization (CF) are $420000.0 (Q4 2025), $406000.0 (Q3 2025), and $394000.0 (Q2 2025).